Suppr超能文献

在小鼠模型中,细胞因子诱导的杀伤细胞成群结队地追捕单个癌细胞。

Cytokine-induced killer cells hunt individual cancer cells in droves in a mouse model.

作者信息

Kim Ji Sung, Kim Yong Guk, Lee Hong Kyung, Park Eun Jae, Kim Boyeong, Kang Jong Soon, Lee Heesoon, Kim Youngsoo, Hong Jin Tae, Han Sang-Bae

机构信息

College of Pharmacy, Chungbuk National University, 194-31 Osongsaengmyung-1, Heungdeok, Cheongju, Chungbuk, 28160, Republic of Korea.

Korea Research Institute of Bioscience and Biotechnology, Cheongju, Chungbuk, 28116, Republic of Korea.

出版信息

Cancer Immunol Immunother. 2017 Feb;66(2):193-202. doi: 10.1007/s00262-016-1934-2. Epub 2016 Nov 25.

Abstract

Cytotoxicity of cytokine-induced killer (CIK) cells depends mainly on their encounters with target cells, but how many CIK cells are required to kill an individual cancer cell is unknown. Here we used time-lapse imaging to quantify the critical effector cell number required to kill an individual target cell. CIK cells killed MHC-I-negative and MHC-I-positive cancer cells, but natural killer (NK) cells destroyed MHC-I-negative cells only. The average threshold number of CIK cells required to kill an individual cancer cell was 6.7 for MHC-I-negative cells and 6.9 for MHC-I-positive cells. That of NK cells was 2.4 for MHC-I-negative cells. Likely due to the higher threshold numbers, killing by CIK cells was delayed in comparison with NK cells: 40% of MHC-negative target cells were killed after 5 h when co-cultured with CIK cells and after 2 h with NK cells. Our data have implications for the rational design of CIK cell-based immunotherapy of cancer patients.

摘要

细胞因子诱导的杀伤细胞(CIK)的细胞毒性主要取决于它们与靶细胞的接触,但杀死单个癌细胞需要多少CIK细胞尚不清楚。在这里,我们使用延时成像来量化杀死单个靶细胞所需的关键效应细胞数量。CIK细胞可杀死MHC-I阴性和MHC-I阳性癌细胞,但自然杀伤(NK)细胞仅破坏MHC-I阴性细胞。杀死单个MHC-I阴性癌细胞所需的CIK细胞平均阈值数量为6.7,杀死单个MHC-I阳性癌细胞所需的CIK细胞平均阈值数量为6.9。NK细胞杀死MHC-I阴性细胞的平均阈值数量为2.4。可能由于阈值数量较高,与NK细胞相比,CIK细胞的杀伤作用有所延迟:与CIK细胞共培养5小时后,40%的MHC阴性靶细胞被杀死,而与NK细胞共培养2小时后,40%的MHC阴性靶细胞被杀死。我们的数据对基于CIK细胞的癌症患者免疫治疗的合理设计具有启示意义。

相似文献

本文引用的文献

7
Trial Watch: Adoptive cell transfer for oncological indications.试验观察:用于肿瘤适应症的过继性细胞转移
Oncoimmunology. 2015 May 5;4(11):e1046673. doi: 10.1080/2162402X.2015.1046673. eCollection 2015 Nov.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验